Insulin decreases the interspike interval (ISI) and cluster pause duration of mitral cell action potential activity. by Debra Ann Fadool (332114)

Comparison of the histopathological changes after KA/E2 treatment in WT and TLR2 KO mice. by Mi-Kyung Park (56053)

Coordinates of O_i point in cylindrical coordinate system. by Weiliang Zhang (11231646)

Cullin1/5/4A degradation is mediated by caspase-1 during <i>Eh</i>-macrophage contact. by Attinder Chadha (11414273)

Subjects:

The frequency of MHV68 infection in mature B cells is decreased in mice depleted of developing B cells. by Carrie B. Coleman (584493)

Ppk1 levels are not affected by decreasing dendrite arbor size but are reduced when dendrite length increases. by Josephine W. Mitchell (17364781)

Image_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.TIF by Britta Hanssen (4898155)

“…Selective motor control (SMC) was assessed on a 5-point scale for the children with SCP. First, the anthropometrics, strength, and muscle size parameters were compared between the cohorts. …”

Table_2_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…Selective motor control (SMC) was assessed on a 5-point scale for the children with SCP. First, the anthropometrics, strength, and muscle size parameters were compared between the cohorts. …”

Table_3_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…Selective motor control (SMC) was assessed on a 5-point scale for the children with SCP. First, the anthropometrics, strength, and muscle size parameters were compared between the cohorts. …”

Table_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…Selective motor control (SMC) was assessed on a 5-point scale for the children with SCP. First, the anthropometrics, strength, and muscle size parameters were compared between the cohorts. …”

Table_1_Decrease in Admissions and Change in the Diagnostic Landscape in a Newborn Care Unit in Northern Ghana During the COVID-19 Pandemic.DOC by Alhassan Abdul-Mumin (5986151)

“…</p><p>Conclusion: We observed a marked decrease in admissions and change in the diagnosis landscape and related mortality during the pandemic. …”

Activation of mitoK_ATP channels decreased the latency time of the transjunctional currents in slice. by Jiangping Wang (281901)

“…The holding potential for both cells was -80 mV. ‘‘a’’ indicates the onset time point of the voltage steps. …”

Decreased risk of Parkinson’s disease in diabetic patients with thiazolidinediones therapy: An exploratory meta-analysis - Fig 2 by Yueli Zhu (7526219)

Pep4 overexpression decreased APCs in Vps21- and ESCRT-mutant cells after nitrogen starvation. by Zulin Wu (4451572)

“…<p><b>A.</b> The accumulation of GFP-Atg8-labeled APCs in mutant cells (<i>vps21Δ</i>, <i>snf7Δ</i>, and <i>vps4Δ</i>) slightly decreased with Pep4 overexpression. …”

File S1 - FLZ Alleviates the Memory Deficits in Transgenic Mouse Model of Alzheimer’s Disease via Decreasing Beta-Amyloid Production and Tau Hyperphosphorylation by Xiu-Qi Bao (479278)

Recombinant CCR5-T4L acts as a HIV-1 co-receptor and down-regulates WT-CCR5 expression on the 3T3T4 cell surface. by Qingwen Jin (767337)

“…WT-CCR5 was used as a positive control. B) CCR5 expression on the cell surface was confirmed using FACS. …”

DPPIV inhibitor MK626 decreases T1D incidence and reduces the insulitis score in NOD mice. by Núria Alonso (824191)

Decreased H3K4me3 in Δ cells is not necessarily due to decreased RNA polymerase II loading () ChIP analysis of H3K4me3 and RNA pol II levels on the locus by Klaas W. Mulder (12134)

Effect of expressing ^H2F1 WT or Znf5 C2>A2 on the REH2 steady-state abundance. by Vikas Kumar (153353)

“…<p><b>(A)</b> Western blots of extracts with tagged ^H2F1 WT (lanes 1–2) or Z5 C2>A2 (Z5; lanes 3–4). …”

Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)